Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is -6.97% vs 9.51% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -50.20% vs -0.15% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is -1.61% vs 10.38% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 2.61% vs -18.39% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Jointown Pharmaceutical Group Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -6.97% vs 9.51% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 6.56% vs -1.54% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -50.20% vs -0.15% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -28.73% vs -13.23% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -1.61% vs 10.38% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -27.15% vs -6.76% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 2.61% vs -18.39% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -23.54% vs -0.18% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






